A detailed history of Ivc Wealth Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ivc Wealth Advisors LLC holds 5,363 shares of BMY stock, worth $291,318. This represents 0.15% of its overall portfolio holdings.

Number of Shares
5,363
Previous 5,580 3.89%
Holding current value
$291,318
Previous $231,000 19.91%
% of portfolio
0.15%
Previous 0.13%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$39.66 - $51.75 $8,606 - $11,229
-217 Reduced 3.89%
5,363 $277,000
Q2 2024

Jul 16, 2024

BUY
$40.25 - $52.99 $224,595 - $295,684
5,580 New
5,580 $231,000
Q4 2023

Jan 10, 2024

SELL
$48.48 - $57.85 $211,712 - $252,630
-4,367 Reduced 52.19%
4,000 $205,000
Q3 2023

Oct 05, 2023

SELL
$57.89 - $64.73 $36,123 - $40,391
-624 Reduced 6.94%
8,367 $485,000
Q2 2023

Jul 13, 2023

BUY
$63.71 - $70.74 $8,919 - $9,903
140 Added 1.58%
8,991 $574,000
Q1 2023

Apr 13, 2023

SELL
$65.71 - $74.53 $8,410 - $9,539
-128 Reduced 1.43%
8,851 $613,000
Q4 2022

Jan 17, 2023

BUY
$68.48 - $81.09 $11,915 - $14,109
174 Added 1.98%
8,979 $0
Q3 2022

Oct 12, 2022

SELL
$0.13 - $76.84 $17 - $10,527
-137 Reduced 1.53%
8,805 $626,000
Q2 2022

Jul 11, 2022

BUY
$72.62 - $79.98 $7,625 - $8,397
105 Added 1.19%
8,942 $689,000
Q1 2022

Apr 27, 2022

BUY
$61.48 - $73.72 $35,289 - $42,315
574 Added 6.95%
8,837 $645,000
Q4 2021

Jan 13, 2022

BUY
$53.63 - $62.52 $14,480 - $16,880
270 Added 3.38%
8,263 $515,000
Q3 2021

Oct 08, 2021

SELL
$59.17 - $69.31 $14,792 - $17,327
-250 Reduced 3.03%
7,993 $473,000
Q2 2021

Jul 13, 2021

SELL
$61.91 - $67.42 $119,176 - $129,783
-1,925 Reduced 18.93%
8,243 $551,000
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $4,450 - $5,005
75 Added 0.74%
10,168 $642,000
Q4 2020

Feb 01, 2021

BUY
$57.74 - $65.43 $582,769 - $660,384
10,093 New
10,093 $626,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ivc Wealth Advisors LLC Portfolio

Follow Ivc Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ivc Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ivc Wealth Advisors LLC with notifications on news.